BIT

8.00%

2.7¢

BIOTRON LIMITED

Market Cap $24.36M Add to my watchlist

Healthcare Biotechnology

Biotron Limited is an Australia-based biotechnology company. The Company is primarily... Biotron Limited is an Australia-based biotechnology company. The Company is primarily engaged in the funding and management of intermediate and applied biotechnology research and development projects. The Company’s clinical programs include BIT225-001, BIT225-003, BIT225-004, BIT225-005, BIT225-006, BIT225-007 and BIT225-008. BIT225 is in mid-stage clinical development for treatment of HIV-1 and Hepatitis C virus (HCV) infections, with seven clinical trials completed. BIT225 is a HIV-1 Vpu protein inhibitor with the aim of inhibiting virus replication in cellular reservoirs. BIT225 is a viral assembly inhibitor that targets HCV p7 protein. In addition to the development of BIT225, the Company has a portfolio of preclinical antiviral programs developing drugs targeting a range of significant established and emerging viral diseases such as Dengue, Zika and Influenza virus.More

Latest Threads

Tag

Subject

BIT

Complete headline results for Commercial Deal, when?

3 4 5

23/08/24

282

65K

23/08/24

Last post vrs37

282

65K

BIT

Is Biotron a Scam and Sham?

22/08/24

1.7K

22/08/24

Last post vrs37

1.7K

BIT

What will be the trigger?

22/08/24

1.4K

22/08/24

Last post a2zz

1.4K

BIT

Ann: Application for quotation of securities - BIT

20/08/24

12K

20/08/24

Last post Compounding69

12K

BIT

Ann: Quarterly Activities/Appendix 4C Cash Flow Report

2 3

15/08/24

159

37K

15/08/24

Last post WelshBuffett

159

37K

BIT

Ann: Letter to Shareholders

2 3

12/08/24

157

46K

12/08/24

Last post $$$$$$$$

157

46K

BIT

BIT Charting

26 27 28

12/08/24

1.6K

489K

12/08/24

Last post WelshBuffett

1.6K

489K

BIT

The Final Countdown

2 3 4

07/08/24

235

63K

07/08/24

Last post WelshBuffett

235

63K

See All Discussions

Timeline

Application for quotation of securities - BIT
15 Aug 11:05	Share

Quarterly Activities/Appendix 4C Cash Flow Report
31 Jul 08:52	Share

Application for quotation of securities - BIT
22 Jul 14:19	Share

Letter to Shareholders
11 Jul 10:35	Share

Webinar Investors Presentation
26 Jun 13:06	Share

BIOTRON CLINICAL TRIAL RESULTS WEBINAR
25 Jun 13:21	Share

BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives
19 Jun 09:47	Share

Change of Share Registry address
23 May 09:41	Share

Quarterly Activities/Appendix 4C Cash Flow Report
26 Apr 08:30	Share

POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
05 Apr 09:38	Share

Response to ASX Price Query
27 Mar 09:05	Share

Half Yearly Report and Accounts
27 Feb 09:06	Share

$1.64M R&D rebate received
08 Feb 13:00	Share

Quarterly Activities/Appendix 4C Cash Flow Report
30 Jan 09:55	Share

Shareholder Update
14 Dec 09:57	Share

Application for quotation of securities - BIT
01 Dec 10:19	Share

Change of Director's Interest Notice MM
27 Nov 12:28	Share

Notification of cessation of securities - BIT
27 Nov 12:22	Share

Results of AGM
22 Nov 11:57	Share

Presentation to Annual General Meeting
22 Nov 08:50	Share

Application for quotation of securities - BIT
10 Nov 10:47	Share

Quarterly Activities/Appendix 4C Cash Flow Report
27 Oct 09:32	Share

Application for quotation of securities - BIT
26 Oct 11:17	Share

Presentation to Investors
24 Oct 09:40	Share

Annual Report/Notice of Annual General Meeting/Proxy Form
20 Oct 09:42	Share

Application for quotation of securities - BIT
10 Oct 14:05	Share

Response to ASX Price Query
29 Sep 11:45	Share

Letter to Shareholders
26 Sep 09:43	Share

Response to ASX Price Query
11 Sep 14:51	Share

Appendix 4G
25 Aug 17:01	Share

View More

(20min delay)
Last 2.7¢		Change 0.002(8.00%)		Mkt cap ! $24.36M

Open	High	Low	Value	Volume
2.6¢	2.8¢	2.5¢	$23.28K	893.7K

Buyers (Bids)

No.	Vol.	Price($)
1	15384	2.6¢

Sellers (Offers)

Price($)	Vol.	No.
2.8¢	396594	2

View Market Depth

No.	Vol.	Price($)
2	114733	0.025
1	41000	0.024
2	153913	0.023
5	4245555	0.022
1	250000	0.021

Price($)	Vol.	No.
0.028	396594	2
0.029	305600	3
0.030	87636	3
0.031	109129	2
0.032	500000	1

Last trade - 16.10pm 23/08/2024 (20 minute delay)


Last 2.8¢		Change 0.002 ( 12.0 %)
Open	High	Low	Volume
2.5¢	2.8¢	2.5¢	326107
Last updated 15.56pm 23/08/2024 ?

BIT (ASX) Chart

BIOTRON LIMITED

Latest Threads

Timeline

Featured News

Latest Articles

Biotron jumps over 14% on latest HIV Phase 2 results; liquidity notably boosted

Shares in otherwise thinly traded healthcare microcap Biotron Limited (ASX:BIT) jumped 14.6% on Wednesday following trial results.

Biotron (ASX:BIT) kicks off phase II COVID-19 clinical trial in Thailand

Biotron (ASX:BIT) has kicked off a phase II trial of its lead antiviral drug, BIT225, to treat COVID-19 within three days of the onset of symptoms over seven days of treatment.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News